Many patients and physicians have been inquiring about the latest treatment for Ulcerative Colitis (UC) with Abbott and Janssen having recently making Tumor Necrosing Factor (TNF) antagonists more readily available for the treatment of moderate to severe UC. The incidence of UC has been increasing and there are now 2.2 to 14.3 cases per 100,000 […]